1. Home
  2. AKTX vs TRSG Comparison

AKTX vs TRSG Comparison

Compare AKTX & TRSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • TRSG
  • Stock Information
  • Founded
  • AKTX N/A
  • TRSG 1996
  • Country
  • AKTX United States
  • TRSG Singapore
  • Employees
  • AKTX N/A
  • TRSG N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • TRSG
  • Sector
  • AKTX Health Care
  • TRSG
  • Exchange
  • AKTX Nasdaq
  • TRSG NYSE
  • Market Cap
  • AKTX 41.8M
  • TRSG 27.0M
  • IPO Year
  • AKTX N/A
  • TRSG 2024
  • Fundamental
  • Price
  • AKTX $1.16
  • TRSG $1.73
  • Analyst Decision
  • AKTX
  • TRSG
  • Analyst Count
  • AKTX 0
  • TRSG 0
  • Target Price
  • AKTX N/A
  • TRSG N/A
  • AVG Volume (30 Days)
  • AKTX 28.1K
  • TRSG 8.4K
  • Earning Date
  • AKTX 08-18-2025
  • TRSG 05-14-2025
  • Dividend Yield
  • AKTX N/A
  • TRSG N/A
  • EPS Growth
  • AKTX N/A
  • TRSG N/A
  • EPS
  • AKTX N/A
  • TRSG N/A
  • Revenue
  • AKTX N/A
  • TRSG $12,810,249.00
  • Revenue This Year
  • AKTX N/A
  • TRSG N/A
  • Revenue Next Year
  • AKTX N/A
  • TRSG N/A
  • P/E Ratio
  • AKTX N/A
  • TRSG N/A
  • Revenue Growth
  • AKTX N/A
  • TRSG N/A
  • 52 Week Low
  • AKTX $0.85
  • TRSG $1.00
  • 52 Week High
  • AKTX $4.40
  • TRSG $4.57
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 43.49
  • TRSG N/A
  • Support Level
  • AKTX $1.15
  • TRSG N/A
  • Resistance Level
  • AKTX $1.22
  • TRSG N/A
  • Average True Range (ATR)
  • AKTX 0.07
  • TRSG 0.00
  • MACD
  • AKTX 0.00
  • TRSG 0.00
  • Stochastic Oscillator
  • AKTX 41.67
  • TRSG 0.00

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About TRSG TUNGRAY TECHNOLOGIES INC

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

Share on Social Networks: